Blue Owl Capital Holdings LP — 13F Holdings & Portfolio
CIK 1858703 · latest 13F-HR filed 2026-05-14
Blue Owl Capital Holdings LP manages $372.2M in 13F-reported U.S. long-equity assets across 76 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are AKTS (15.20%), LRMR (8.61%), ENGNW (8.08%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 20 new positions, exited 25, added to 17, and trimmed 29.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$372.2M
Long-equity book
76
Distinct positions
2026-03-31
Filed 2026-05-14
+20 / −25 / ↑17 / ↓29
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- MAPLIGHT THERAPEUTICS INC$14.7M +256.0%
- LARIMAR THERAPEUTICS INC$6.0M +23.2%
- EYEPOINT INC$4.6M +64.0%
- CULLINAN THERAPEUTICS INC$2.8M +11.5%
- CONTEXT THERAPEUTICS INC$2.4M +22.0%
Top Trims
- SAGIMET BIOSCIENCES INC-$5.6M -76.3%
- DELL TECHNOLOGIES INC-$4.5M -66.3%
- HOLLEY INC-$4.1M -24.0%
- CIVEO CORP CDA-$3.7M -43.6%
- BLUE OWL CAPITAL CORPORATION-$3.5M -13.4%
New Positions
- AKTIS ONCOLOGY INC$56.6M
- CORVUS PHARMACEUTICALS INC$8.0M
- RHYTHM PHARMACEUTICALS INC$5.3M
- COMPASS PATHWAYS PLC$5.1M
- OVID THERAPEUTICS INC$4.2M
Exited Positions
- REPARE THERAPEUTICS INC$9.0M
- PROCORE TECHNOLOGIES INC$6.9M
- ROIVANT SCIENCES LTD$5.7M
- IMMUNEERING CORP$4.4M
- PAYONEER GLOBAL INC$4.0M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | AKTIS ONCOLOGY INC | AKTS | 01021M104 | $56.6M | 15.20% | 3,161,348 | SH |
| 2 | LARIMAR THERAPEUTICS INC | LRMR | 517125100 | $32.0M | 8.61% | 7,120,007 | SH |
| 3 | ENGENE HOLDINGS INC | ENGNW | 29286M105 | $30.1M | 8.08% | 4,416,353 | SH |
| 4 | NUVEEN CHURCHILL DIRECT LEND | NCDL | 67090S108 | $27.3M | 7.33% | 2,143,626 | SH |
| 5 | CULLINAN THERAPEUTICS INC | CGEM | 230031106 | $27.1M | 7.29% | 1,909,764 | SH |
| 6 | BLUE OWL CAPITAL CORPORATION | OBDC | 69121K104 | $22.6M | 6.08% | 2,045,070 | SH |
| 7 | MAPLIGHT THERAPEUTICS INC | MPLT | 56565P103 | $20.5M | 5.49% | 1,005,929 | SH |
| 8 | COMPASS THERAPEUTICS INC | CMPX | 20454B104 | $15.6M | 4.18% | 2,941,525 | SH |
| 9 | CONTEXT THERAPEUTICS INC | CNTX | 21077P108 | $13.3M | 3.58% | 5,089,015 | SH |
| 10 | HOLLEY INC | HLLY | 43538H103 | $13.0M | 3.49% | 4,236,888 | SH |
| 11 | EYEPOINT INC | EYPT | 30233G209 | $11.8M | 3.16% | 912,594 | SH |
| 12 | CORVUS PHARMACEUTICALS INC | CRVS | 221015100 | $8.0M | 2.14% | 545,000 | SH |
| 13 | CONDUENT INC | CNDT | 206787103 | $6.4M | 1.73% | 5,036,595 | SH |
| 14 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 90400D108 | $6.3M | 1.70% | 302,638 | SH |
| 15 | AQUESTIVE THERAPEUTICS INC | AQST | 03843E104 | $5.6M | 1.50% | 1,347,932 | SH |
| 16 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $5.3M | 1.44% | 61,455 | SH |
| 17 | COMPASS PATHWAYS PLC | CMPS | 20451W901 | $5.0M | 1.34% | 904,504 | SH |
| 18 | IMMIX BIOPHARMA INC | IMMX | 45258H106 | $5.0M | 1.34% | 547,552 | SH |
| 19 | IMAGENEBIO INC | IMA | 45175G207 | $4.8M | 1.29% | 959,337 | SH |
| 20 | CIVEO CORP CDA | CVEO | 17878Y207 | $4.8M | 1.28% | 180,475 | SH |
| 21 | LENZ THERAPEUTICS INC | LENZ | 52635N103 | $4.6M | 1.25% | 506,722 | SH |
| 22 | ELEDON PHARMACEUTICALS INC | ELDN | 28617K101 | $4.4M | 1.18% | 1,419,912 | SH |
| 23 | KALVISTA PHARMACEUTICALS INC | KALV | 483497103 | $4.3M | 1.16% | 215,000 | SH |
| 24 | OVID THERAPEUTICS INC | OVID | 690469101 | $4.2M | 1.14% | 1,904,666 | SH |
| 25 | PALVELLA THERAPEUTICS INC NE | PVLA | 697947109 | $3.9M | 1.05% | 31,259 | SH |
| 26 | PLIANT THERAPEUTICS INC | PLRX | 729139105 | $3.7M | 1.01% | 2,969,199 | SH |
| 27 | STARWOOD PPTY TR INC | STWD | 85571B105 | $2.7M | 0.73% | 158,545 | SH |
| 28 | ADC THERAPEUTICS SA | ADCT | H0036K147 | $2.6M | 0.70% | 733,568 | SH |
| 29 | EVOMMUNE INC | EVMN | 30054Y107 | $2.3M | 0.62% | 100,000 | SH |
| 30 | DELL TECHNOLOGIES INC | DELL | 24703L202 | $2.3M | 0.61% | 13,899 | SH |
| 31 | LARIMAR THERAPEUTICS INC | LRMR | 517125900 | $1.9M | 0.51% | 975,700 | SH |
| 32 | ORIC PHARMACEUTICALS INC | ORIC | 68622P109 | $1.9M | 0.51% | 150,000 | SH |
| 33 | SAGIMET BIOSCIENCES INC | SGMT | 786700104 | $1.7M | 0.47% | 333,877 | SH |
| 34 | WW INTL INC | WW | 98262P200 | $1.3M | 0.35% | 95,634 | SH |
| 35 | ENGENE HOLDINGS INC | ENGNW | 29286M113 | $1.3M | 0.35% | 511,177 | SH |
| 36 | ENTERPRISE PRODS PARTNERS L | EPD | 293792107 | $1.2M | 0.32% | 31,290 | SH |
| 37 | FOLD HLDGS INC | FLD | 29103K100 | $1.1M | 0.30% | 856,632 | SH |
| 38 | SYNTEC OPTICS HLDGS INC | OPTXW | 87169M113 | $867.4K | 0.23% | 803,132 | SH |
| 39 | MARKER THERAPEUTICS INC | MRKR | 57055L206 | $720.5K | 0.19% | 554,250 | SH |
| 40 | MINERALYS THERAPEUTICS INC | MLYS | 603170901 | $590.0K | 0.16% | 200,000 | SH |
| 41 | NIOCORP DEVS LTD | NIOBW | 654484153 | $525.0K | 0.14% | 320,100 | SH |
| 42 | COMPASS THERAPEUTICS INC | CMPX | 20454B904 | $500.0K | 0.13% | 400,000 | SH |
| 43 | BRAND ENGAGEMENT NETWORK INC | BNAIW | 104932116 | $416.7K | 0.11% | 1,666,808 | SH |
| 44 | CARDINAL HEALTH INC | CAH | 14149Y108 | $363.0K | 0.10% | 1,718 | SH |
| 45 | REZOLVE AI PLC | RZLVW | G75398118 | $202.2K | 0.05% | 235,121 | SH |
| 46 | PIPER SANDLER COMPANIES | PIPR | 724078209 | $185.9K | 0.05% | 2,428 | SH |
| 47 | ALPHA MODUS HLDGS INC | AMOD | 020952107 | $145.8K | 0.04% | 394,078 | SH |
| 48 | COMPASS PATHWAYS PLC | CMPS | 20451W901 | $132.0K | 0.04% | 900,000 | SH |
| 49 | ENERGY TRANSFER L P | ET | 29273V100 | $102.8K | 0.03% | 5,326 | SH |
| 50 | CID HOLDCO INC | DAIC | 171756109 | $94.8K | 0.03% | 557,361 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | $372.2M | 76 | 0001193125-26-223563 |
| 2025-12-31 | 2026-02-20 | $324.0M | 82 | 0001193125-26-061298 |
| 2025-12-31 | 2026-02-09 | $1.34B | 83 | 0001193125-26-042263 |